175 related articles for article (PubMed ID: 17931792)
1. c-KIT expression in columnar cell lesions of the breast accompanied by benign and malignant breast diseases.
Polat A
Pathol Res Pract; 2007; 203(11):765-9. PubMed ID: 17931792
[TBL] [Abstract][Full Text] [Related]
2. Expression of c-kit protein in proliferative lesions of human breast: sexual difference and close association with phosphotyrosine status.
Tsuura Y; Suzuki T; Honma K; Sano M
J Cancer Res Clin Oncol; 2002 May; 128(5):239-46. PubMed ID: 12029439
[TBL] [Abstract][Full Text] [Related]
3. Assessment of "grading" with Ki-67 and c-kit immunohistochemical expressions may be a helpful tool in management of patients with flat epithelial atypia (FEA) and columnar cell lesions (CCLs) on core breast biopsy.
Tomasino RM; Morello V; Gullo A; Pompei G; Agnese V; Russo A; Rinaldi G
J Cell Physiol; 2009 Nov; 221(2):343-9. PubMed ID: 19585492
[TBL] [Abstract][Full Text] [Related]
4. Expression of c-kit proto-oncogene product in breast tissue.
Yared MA; Middleton LP; Meric F; Cristofanilli M; Sahin AA
Breast J; 2004; 10(4):323-7. PubMed ID: 15239791
[TBL] [Abstract][Full Text] [Related]
5. Expression of c-kit in common benign and malignant breast lesions.
Kondi-Pafiti A; Arkadopoulos N; Gennatas C; Michalaki V; Frangou-Plegmenou M; Chatzipantelis P
Tumori; 2010; 96(6):978-84. PubMed ID: 21388062
[TBL] [Abstract][Full Text] [Related]
6. Expression of c-kit in adenoid cystic carcinoma of the breast.
Crisi GM; Marconi SA; Makari-Judson G; Goulart RA
Am J Clin Pathol; 2005 Nov; 124(5):733-9. PubMed ID: 16203286
[TBL] [Abstract][Full Text] [Related]
7. Heterogeneous immunoreactivity of frozen human benign and malignant breast lesions to C-MYC and C-Ha-ras cellular oncogenes.
Pechoux C; Chardonnet Y; Chignol MC; Noël P
Histol Histopathol; 1994 Jan; 9(1):35-44. PubMed ID: 8003818
[TBL] [Abstract][Full Text] [Related]
8. Expression of c-myc, erbB-2, p53 and nm23-H1 gene product in benign and malignant breast lesions: coexpression and correlation with clinicopathologic parameters.
Sirotkovic-Skerlev M; Krizanac S; Kapitanovic S; Husnjak K; Unusic J; Pavelic K
Exp Mol Pathol; 2005 Aug; 79(1):42-50. PubMed ID: 16005711
[TBL] [Abstract][Full Text] [Related]
9. Expression of the 21,000 molecular weight ras protein in a spectrum of benign and malignant human mammary tissues.
Ohuchi N; Thor A; Page DL; Hand PH; Halter SA; Schlom J
Cancer Res; 1986 May; 46(5):2511-9. PubMed ID: 3084069
[TBL] [Abstract][Full Text] [Related]
10. Clinical, histopathologic, and immunohistochemical features of microglandular adenosis and transition into in situ and invasive carcinoma.
Khalifeh IM; Albarracin C; Diaz LK; Symmans FW; Edgerton ME; Hwang RF; Sneige N
Am J Surg Pathol; 2008 Apr; 32(4):544-52. PubMed ID: 18300793
[TBL] [Abstract][Full Text] [Related]
11. CD117 and CD34 staining patterns in childhood benign mammary lesions.
Kaçar A; Paker I; Akbiyik F; Arikök AT; Mambet E
Turk Patoloji Derg; 2012; 28(1):31-7. PubMed ID: 22207429
[TBL] [Abstract][Full Text] [Related]
12. Inhibitor of differentiation is overexpressed with progression of benign to malignant lesions and related with carcinoembryonic antigen-related cell adhesion molecule 1 distribution in mammary glands.
Liu Q; Yang YM; Zhang QH; Zhang TG; Zhou Q; Zhou CJ
Ann Diagn Pathol; 2011 Feb; 15(1):30-6. PubMed ID: 21106423
[TBL] [Abstract][Full Text] [Related]
13. The mucinous variant of columnar cell lesions.
Verschuur-Maes AH; Van Diest PJ
Histopathology; 2011 May; 58(6):847-53. PubMed ID: 21585423
[TBL] [Abstract][Full Text] [Related]
14. Differential expression of keratins 13 and 16 in normal epithelium, benign lesions, and ductal carcinomas of the human breast determined by the monoclonal antibody Ks8.12.
Pellegrino MB; Asch BB; Connolly JL; Asch HL
Cancer Res; 1988 Oct; 48(20):5831-6. PubMed ID: 2458830
[TBL] [Abstract][Full Text] [Related]
15. Elevated expression of the myc gene in human benign and malignant breast lesions compared to normal tissue.
Spandidos DA; Pintzas A; Kakkanas A; Yiagnisis M; Mahera H; Patra E; Agnantis NJ
Anticancer Res; 1987; 7(6):1299-304. PubMed ID: 3327455
[TBL] [Abstract][Full Text] [Related]
16. Cathepsin-D expression in breast lesion: an immunohistochemical study.
Brujan I; Mărgăritescu C; Simionescu C; Pirici D; Fronie A; Foarfă C; Stepan A; Vrabete M
Rom J Morphol Embryol; 2009; 50(1):31-9. PubMed ID: 19221643
[TBL] [Abstract][Full Text] [Related]
17. Malignant phyllodes tumours show stromal overexpression of c-myc and c-kit.
Sawyer EJ; Poulsom R; Hunt FT; Jeffery R; Elia G; Ellis IO; Ellis P; Tomlinson IP; Hanby AM
J Pathol; 2003 May; 200(1):59-64. PubMed ID: 12692842
[TBL] [Abstract][Full Text] [Related]
18. Immunohistochemical studies on c-erbB-2 oncoprotein expression in paraffin embedded tissues in invasive and non-invasive human breast lesions.
Pechoux C; Chardonnet Y; Noël P
Anticancer Res; 1994; 14(3B):1343-60. PubMed ID: 7915095
[TBL] [Abstract][Full Text] [Related]
19. The use of immunohistochemical probes in the study of benign and malignant breast disease.
Gusterson BA; Warburton MJ; Monaghan P; Foster C; Edwards P; Kraft N; Smith C; Mitchell D; Rudland PS; Neville AM
Behring Inst Mitt; 1984 May; (74):39-48. PubMed ID: 6383328
[TBL] [Abstract][Full Text] [Related]
20. HYOU1/Orp150 expression in breast cancer.
Stojadinovic A; Hooke JA; Shriver CD; Nissan A; Kovatich AJ; Kao TC; Ponniah S; Peoples GE; Moroni M
Med Sci Monit; 2007 Nov; 13(11):BR231-239. PubMed ID: 17968289
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
